Siabu, Robytheresa S.

HRN: 29-02-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2026
MUPIROCIN 2%, 15G (TUBE)
05/19/2026
05/26/2026
TOPICAL
2%
OD
S/P LSTCS With BTL
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines